XTL Biopharmaceuticals Ltd.

Foreign Filer Report • Aug 10, 2023

_________ false

��-���� ������� ��"�	2 380
CAN-FITE BIOPHARMA LTD
Corporation no: 512022153	4329
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	10/08/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-092520	Time of broadcast: 16:43 16:43

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on_________

ea182824-6k_xtlbiopharmaEDGAR3_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 08/08/2023
Address: Bareket 10 , Petach-Tikva 47190   , Tel: 03-9241114 , 03-9213501 Fax: 03-9249378
E-mail address: motti@canfite.co.il   Company site: www.canfite.com
Previous names of reporting entity:
Name of the Signatory: KANTOR RONEN Position of Signatory in the reporting corporation: External Legal Counsel Name of Employer Company:
Address: Metzada 7 , Bnei Brak 5126112 Telephone: 03-6133371 Facsimile: 03-6133372 E-mail: rkantor@DTKGC.com 1